Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Immunaeon logo — Connecting Today's Science to Tomorrow's Cures

Immunaeon

Connecting Today's Science to Tomorrow's Cures

Founded 2019 United States Buffalo, United States 5 employees Unknown Total: $480.00K Biopharma, Biotechnology +2

General Information

Company Name Immunaeon
Founded Year 2019
Location United States Buffalo, United States +1
Employees 5
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Unknown
Social

Get notified when Immunaeon moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Immunaeon

Immunaeon, known for its slogan "Connecting Today's Science to Tomorrow's Cures", is a biotech pioneer established in 2019 in the United States. The company positions itself at the forefront of immunotherapy and biotechnology innovation, aiming to transform healthcare by leveraging advanced genetics and computational sciences.

Focusing on serious diseases like cancer, autoimmune, and infectious diseases, Immunaeon is dedicated to discovering precision-targeted therapeutics that enhance the body's immune response. The organization combines the talents of scientists, clinicians, and bioengineers to foster breakthroughs in medical science.

The latest investment totaling $250.00K was received as an angel investment from University Ventures on 01 March 2023, indicating strategic interest and financial backing. As part of the Biopharma and Health Care industries, Immunaeon continually seeks to push the boundaries of medical research, promising bright prospects for investors focused on transformative healthcare solutions.

Taxonomy: immunotherapy, genetic sciences, computational sciences, precision-targeted therapeutics, cellular biology, cancer treatment, autoimmune disorders, infectious diseases, immune cell storage, breakthrough treatments, immunology research, therapeutic innovation, immune system analysis, healthcare transformation

Services & Products

immune cell isolation
cell analysis and preservation
immunotherapy preparation
health resilience planning

Target Customers

individuals with a family history of cancer individuals with autoimmune disorders health-conscious individuals patients seeking proactive healthcare

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Angel •••••• 1
Investor
01 Mar 2023
Seed •••••• 1
Investor
01 Jun 2022
Seed •••••• 1
Investor
01 Oct 2021
Grant •••••• 1 •••• •••• 01 Sep 2020

Immunaeon Alternatives & Competitors

Immunaeon vs
Cogen Therapeutics
Cogen Therapeutics

Pioneering immune modulation to specifically address disease drivers, redefining immunological healt...

Biotechnology
Immunaeon vs
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. United States

Harnessing the power of the immune system to develop treatments for cancer.

Unknown
23 employees
Biotechnology
Immunaeon vs
NKGen Biotech, Inc.
NKGen Biotech, Inc. United States

Maximizing immune integrity through the development of unique natural killer (NK) cell therapies.

54 employees

FAQ About Immunaeon

Connecting Today's Science to Tomorrow's Cures
Immunaeon was founded in 2019.
Immunaeon is headquartered in Buffalo, United States.
Immunaeon operates in the following industries: Biopharma, Biotechnology, Health Care, Health and Wellness.
Immunaeon has approximately 5 employees.
Immunaeon has completed 4 funding rounds, raising a total of $480.00K. The latest funding stage is Unknown.
Immunaeon offers: immune cell isolation, cell analysis and preservation, immunotherapy preparation, health resilience planning.
Top alternatives and competitors to Immunaeon include Cogen Therapeutics, Tizona Therapeutics, Inc., NKGen Biotech, Inc., 3T Biosciences, La Jolla Institute for Immunology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Immunaeon and Cogen Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Immunaeon and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy